Tenax Therapeutics, Inc. · NASDAQ:TENX
Giordano Christopher Thomas exercised options for 8,719 Tenax Therapeutics, Inc. shares (Form 4)
Traded Jul 13, 2026 · Filed Jul 14, 2026
On Jul 13, 2026, Giordano Christopher Thomas (Director, CEO) exercised options for 8,719 Tenax Therapeutics, Inc. shares at an average US$5.88 for US$51,267, leaving 11,324 shares. Filed Jul 14, 2026 (Form 4).
- Options exercised
- 8,719 shares
- Price
- US$5.88 average (US$3.55 to US$5.94)
- Value
- US$51,267
- Holding after
- 11,324 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | Option exercise | 219 | US$3.55 | 2,824 | Direct |
| Jul 13, 2026 | Common Stock | Option exercise | 8,500 | US$5.94 | 11,324 | Direct |
Source
Related
- Tenax Therapeutics, Inc.
- Giordano Christopher Thomas
- Tenax Therapeutics, Inc. shareholders
- Form 4 · Giordano Christopher Thomas · Sep 15, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026
- Form 4 · Staab Thomas R II · Sep 15, 2026